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Depression is a mental illness that requires prompt identification and treatment due to 
grave consequences if untreated. Depression can affect a person’s level of functioning, 
lead to worsening health conditions, comorbid substance abuse, and suicide. Despite 
these facts, the current state of nursing practice includes an inadequate diagnosis of 
patients with depression, lack of guidelines for the use of assessment tools and diagnostic 
tests to identify depression, and insufficient information concerning the accuracy of 
depression assessment tools.  This systematic literature review examined 6 depression 
assessment tools in regard to their accuracy as identified by specificity, sensitivity, 
reliability, and validity. This project also examined the pros and cons, demographics, and 
healthcare settings that use these depression inventory tools. This project used the 
Orlando nursing process theory as a theoretical framework. Based on the review of 10 
articles selected, evidence showed that the Hamilton depression rating scale has the 
highest sensitivity (93%) and specificity (97%) rates. The implications for positive social 
change include the opportunity for clinicians to use the findings of this project in their 
selection of depression assessment tools in healthcare settings. Other researchers can use 
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Section 1: Nature of the Project 
Introduction 
The nature of this project was a systematic review of the literature concerning the 
use of depression inventory tools and diagnostic tests for management of patients with a 
depression diagnosis. In this project, I reviewed the pros and cons, characteristics, and 
indications of depression screening tools published in peer-reviewed literature between 
2012 and 2017. Physicians and nurse practitioners could use the compiled information 
from this project to objectively select an appropriate tool to assess and monitor recovery 
of patients with the diagnosis of depression in an outpatient setting. 
Primary care doctors and clinicians working in an outpatient setting frequently 
rely on patient responses to endorse items on self-report measures to develop a diagnosis 
(Bieling, McCabe, & Antony, 2004). The diagnosis of depression can be made with 
depressed mood or anhedonia with at least four or more of the accompanying symptoms 
in the previous 2 weeks, affecting a patient’s level of functioning at work, school, or 
home (American Psychiatric Association [APA], 2010). The diagnostic criteria for 
depressive disorder, also known as clinical depression or depression, includes a depressed 
mood or loss of interest or pleasure in daily activities lasting at least 2 weeks 
(PsychCentral, 2017). The accompanying symptoms include increased or decreased 
sleep, decreased interest, a sense of guilt or worthlessness, decreased energy or easily 
fatigued, inability to concentrate or make decisions, decreased or increased appetite and 
weight, increased or decreased psychomotor activity, and suicidal ideation (Institute of 




background of the project, practice problem, project-focused question, and framework 
guiding the project. I also address any limitations and the significance of the project in 
advancing the quality of care provided by clinicians by using depression assessment 
inventory tools. 
Mental health disorders are a leading cause of disability in the United States 
(National Institute of Mental Health [NIMH], 2008). Recent statistics for depression 
among U.S adults are alarming. NIMH (2016) estimated that in 2015, 16.1 million adults 
aged 18 years or older in the United States had at least one major depressive episode, 
with this number representing 6.7% of all U.S. adults. The effects of depression can be 
self-limiting and devastating on patients, families, and the community as a whole. 
Depression is a mental health disorder ranked as a leading behavioral health disorder 
although it continues to be underrecognized and undermanaged in health care settings. 
Depression is projected to be the second largest cause of disability by the year 2020, but 
it is not often treated adequately (Maurer, 2012). Figure 1 shows depression prevalence 
among the U.S. adult population, whereas Figure 2 illustrates the prevalence of adult 
patients in the United States with severe impairment due to depression among different 






Figure 1. 12-month prevalence of depression among U.S. adults (2015). Source: NIMH 
(2016a). 12-month prevalence of major depressive episode among U.S. adults. Notes. 
Adapted directly from https://www.nimh.nih.gov/health/statistics/prevalence/major-





Figure 2. 12-month prevalence of major depressive episodes with severe impairment 
(2015). Source: NIMH (2016b). 12-month prevalence of depression with severe 
impairment. Notes. Adapted directly from 
https://www.nimh.nih.gov/health/statistics/prevalence/major-depression-with-severe-
impairment-among-adults.shtml. No permission required to use the figure. 
Although the effects of depression are of national concern, it is disheartening that 
rates of treatment remain low, and the treatment received is often inadequate (Pratt & 
Brody, 2014). My goals in this project included contributing to the existing literature 
concerning the management of depression from identifying the risk factors and present 
valuable information on assessment tools and diagnostic tests in a report that could be 
used by health care providers in clinical settings. Understanding the risk factors for 
depression is a step toward the ability to identify the causative factors and address the 




Chronic medical illness 
Chronic minor daily stress 
Chronic pain syndrome 
Family history of depression 
Female sex 
Low income/job loss 
Low self-esteem 
Low social support 
Prior depression 
Single/divorced/widowed 
Traumatic brain injury 
Younger age 
Figure 3. Risk factors for depression. Adapted from source: Maurer, D. M. (2012). 
Screening for depression. Depression, 100, 23. 
Maurer (2012) listed the risk factors of depression as chronic medical illness, 
chronic minor daily stress, chronic pain syndrome, family history of depression, female 
sex, low income/job loss, low self-esteem, low social support, prior depression, 
unmarried, divorced, or widowed, traumatic brain injury, and younger age. Therefore, 
being able to identify patients at high risk of developing this illness is crucial. 
Depression can take different forms, but for the sake of this project, depression 
refers only to major depressive disorder (MDD) without psychosis. Therefore, this 
project excluded other forms of depression such as persistent depressive disorder, 
perinatal depression, bipolar depression, psychotic depression, and seasonal affective 
disorder. Differentiating MDD from other types of depression is significant regarding 
illness identification and applying appropriate treatment modalities. 
The doctorate of nursing practice (DNP) nurse is often involved in the review of 
health care publications and functions as part of the team to develop evidence-based 
guidelines for his or her organization. This entails reviewing existing health care 




this project is a systematic review of the literature concerning the diagnosis of 
depression; this researcher studied the different assessment tools and diagnostic tests used 
in the management of a major depressive episode. Hence, this doctoral project was 
guided by the Walden University Manual for Systematic Review of Literature. 
Multiple depression inventory tools can help diagnose depression in patients. No 
previous research has explored in detail whether one measurement or assessment tool has 
better predictability value compared with another or whether it functions in the company 
of other measures to increase diagnostic accuracy. This researcher reviewed existing 
evidence concerning assessment tools and diagnostic tests that could be used to improve 
health outcomes for patients with depression. 
The need to accurately diagnose and manage patients with depression has never 
been more important than now. The effects of depression nationally and globally are 
significant. Maurer (2012) estimated the medical costs of depression to be $43 billion and 
put its price in low productivity at $17 billion annually. It is estimated to affect 5% to 
13% of patients in primary care settings (Maurer, 2012). The effects of depression on 
patients, their families, and the communities have led to the need to screen patients 
accurately and manage their recovery objectively using appropriate measures. The 
development of a guideline using this systematic review of the literature improves 
diagnosis of patients with depression and makes a significant contribution to the existing 





Louch (2008) indicated depression as a disease poses significant problems when 
not diagnosed and not treated effectively. The estimated medical cost of depression is $43 
billion annually, and it costs economic productivity more than $17 billion annually 
(Maurer, 2012). Depression could lead to profound and overwhelming feelings of sadness 
that could negatively affect the patient’s life, career, relationship with others, educational 
pursuits, and self-care habits. It can result in self-harm, irritability, anger, passing blame, 
and posing a threat to others. The feeling of depression can last a short period or for even 
a lifetime, and the economic implications on society can be enormous. 
In terms of local relevance, the problem identified with typical practice in some 
health care settings includes subjective assessments with patients describing the level of 
depression using a numerical rating scale from 0 to 10, with 10 being severe depression, 
and patients describing accompanying signs, symptoms, and contributing factors to 
formulate the diagnosis and treatment plan (Okonofua, 2017). In practice, patients with a 
diagnosis of MDD or simply “depression” seen in primary care settings may not receive a 
diagnosis and treatment for depression. Therefore, having a guide for assessment and 
treatment of depression in the primary care setting is needed. For this project, the focus 
was on the identification of evidence-based information and evaluation tools for the 
diagnosis and management of depression in a primary care setting. I expected to address 
the difficulty in finding any single publication covering measures and diagnostic tests for 




Implications of depression can be severe and costly. According to the Centers for 
Disease Control (CDC; 2017), “In the United States, the economic burden of depression 
in 2010 was $210 billion, which includes the cost of workplace displacement, direct 
management, and treatment of depression and depression-related suicides or attempted 
suicides” (p. 1). Depression increases the risk of suicide-related morbidity and mortality, 
workplace absenteeism, lower productivity, anxiety, irritability, smoking, substance use, 
and eating disorders (CDC, 2017). The effects of depression on individuals, families, and 
the society as a whole are enormous, and accurate diagnosis and treatment are of utmost 
importance. Effects of depression have also been linked to self-destruct behaviors such as 
alcohol use, use of illicit substances, and misuse of prescribed medications. Davis, 
Uezato, Newell, and Frazier (2008) explained that nearly one-third of patients with MDD 
also have substance use disorders, which leads to a higher risk for suicide, greater social 
and personal impairment, and a higher rate for psychiatric conditions. 
DNP nurses are at the forefront of using evidence-based resources to transform 
health care, design treatment protocols, and improve health outcomes for patients. 
Depression is an illness that, when undiagnosed or untreated, can have grave 
consequences for the patients, families, and the community as a whole. Depression is an 
illness that has implications at local, national, and international levels. 
This doctoral project holds significance for the field of nursing practice. 
Depression demands long and costly treatment protocols. Mainly, treatment is 
inadequate; even when appropriate treatment is applied, there is incidence of recurrent 




dislocations. Maurer (2012) stated depression is often not adequately treated, and even 
when treated appropriately, more than 75% of patients with depression have recurrent 
episodes, and 10% to 30% have residual symptoms. 
The ability to quantify the level of depression or residual depression symptoms 
following treatments depends on the use of appropriate assessment tools. This doctoral 
project is significant to the field of nursing practice in more ways than one. DNP nurses 
play a significant role in health care research, health-related problem identification, 
proposing solutions, health care policy formation, and health care advocacy. Advanced 
practice nurses are leaders in health care practice who review problems within health care 
settings while formulating the appropriate solutions. 
Purpose 
In this DNP project, I systematically reviewed existing literature, compiled 
information on accuracy, and examined pros and cons of different depression inventory 
tools and diagnostic tests for management of depression with the goal of improving 
quality of care provided to patients by clinicians. Likewise, this doctoral project holds 
significance for the field of nursing practice in that there is a gap in the practice in the 
outpatient setting regarding the lack of use of assessment tools. I reviewed some 
depression scales that have been used to diagnose and treat patients with depressive 
disorders in a primary care setting. These assessment tools included the Beck depression 
inventory (BDI), Hamilton depression rating scale (HDRS), patient health questionnaire 
(PHQ-2 and PHQ-9), a major depression inventory (MDI), Zung self-rating depression 




I compiled current evidence concerning the use of depression assessment tools 
regarding their accuracy (identified by specificity, sensitivity, reliability, and validity), 
their advantages, disadvantages, possibly demographics, and health care settings from 
existing literature. I also reviewed basic lab tests that could be used to rule out medical 
illnesses that can present as depressed mood. The final product of the project was 
depression treatment resource material used in primary care settings. 
The practice-focused question was: What are the characteristics and indications of 
the major depression screening tools/diagnostic tests published in peer-reviewed 
literature between 2012 and 2017 for adult patients? 
The use of a population, intervention, comparison, and outcome (PICO) question 
for this project increases “the likelihood that the best evidence to inform practice will be 
found quickly and efficiently” (Stillwell, Fineout-Overholt, Melnyk, & Williamson, 
2010, p. 58). The PICO for this project was as follows: 
• P (population): adult patients in an outpatient clinic from ages 18 to 50 years, 
• I (intervention): use of assessment tools and recommended diagnostic tests to 
diagnose depression, 
• C (comparison): non-use of assessment tools and recommended diagnostic tests to 
diagnose depression, and 
• O (outcome): improved health outcomes for patients with depression. 
There is an existing gap-in-practice whereby management of depression lacks an 
easily accessible guide that compares the reliability of the depression inventory tools or 




practice. The compilations of the depression assessment tools and diagnostic tests in a 
tabular form make the results of this project readily available for health care 
professionals, clinicians, patients, and family members to read and use for the 
management of depression. 
Nature of the Doctoral Project 
This project was a systematic review of the literature examining published articles 
on depression assessment and treatment in primary care settings from the years 2012 to 
2017. Studies involved patients of mixed race, males, and females between ages 18 to 50 
years. Sources of evidence included Walden University Library databases, online 
scholarly articles, and search engines such as Google Scholar. Once I completed the 
systematic review of the literature, I provided the findings to the clinical setting as an 
educational session on depression assessment tools and diagnostic tests for the 
management of depression diagnosis. 
I tabulated all diagnostic and assessment tools identified and reviewed  using a 
Microsoft Excel spreadsheet. The report included several headings including depression 
assessment tools, the number of articles reviewed, the accuracy of the tools regarding 
sensitivity, specificity, reliability, validity, age groups, or demographics for using the 
assessment tool, type of health care setting, and advantages and disadvantages of the 
assessment tools as identified from existing literature. 
Significance of the Project 
The stakeholders affected by this project included patients, families, health care 




accurately, effectively, and efficiently diagnose patients with depressive disorders on 
specificity, sensitivity, and objectivity. The identification of accurate assessment tools 
assists in the management of diagnosis and treatment of depression in primary care 
settings. This study contributes to the body of evidence-based resources for the care of 
patients with depressed mood. 
For the patients, this project produced a compilation of assessment tools for the 
diagnosis of depression best fitted for certain age groups or demographics. For the health 
care providers and patients, the project helped identify the advantages and disadvantages 
of tools used for depression diagnosis, and the project helped answer the question of 
whether the assessment tools accurately measured depression among patients. 
The project is valuable to health care professionals, businesses, and associations 
at local, national, and global levels. Depression is an illness identified as a global 
concern. It is the fourth leading cause of disability worldwide, and by 2020, it will be the 
second leading cause according to World Health Organization projections (WHO, 2008). 
This project is of importance to nursing practice and applies to other health care 
professions. The potential of transferability of this project to related practice sectors such 
as psychology and public health fields is high. There are also potential implications of 
positive social change using the findings of this doctoral project. The use of results of this 
project could lead to a change in behavior and a change in practice modalities of health 
care professionals or clinicians. Furthermore, these objective criteria could serve as a 






Effective diagnosis and management of depression can be complicated. 
Identifying accurate, effective, and efficient assessment tools and diagnostic tests assists 
in the proper identification and management of depression in patients. This project is a 
compilation of depression assessment tools with a view to identifying their accuracy 
regarding their specificity, sensitivity, reliability, validity, advantages, and disadvantages. 
This project concludes with objective criteria for making a correct diagnosis of 
depression in a primary health care setting. 
Section 1 of this project covered the introduction, problem statement, research 
questions, relevance of addressing this topic locally, and the project’s relevance to the 
field of nursing practice. I also identified the meaningful gap-in-practice and how I hoped 
to fill the gap, the sources of evidence, the plan on how to compile findings, and a 
statement on how the project could be of significance to other similar practice areas. 
In the next section, I address the background and context of the doctoral project, 
concepts, models or theories, and the relevance of the doctoral topic to nursing practice, 




Section 2: Background and Context 
Introduction 
Depression is a serious mental illness that is treatable, yet, can involve disabling 
life events or can lead to suicide. Among patients diagnosed with depression, the rate of 
suicide is approximately 10% to 15% (Lichtblau, 2011). The need to address this silent 
epidemic has never been as urgent as now, demanding the attention of health care 
providers, health care organizations, the government, patients, and families. The absence 
of guidelines for assessment and management of patients diagnosed with depression 
complicates this practice problem because few studies have been conducted to ascertain 
the adequacy of assessment tools used for depression. 
For this project, the practice-focused question was: What are the characteristics 
and indications of the major depression screening tools published in peer-reviewed 
literature between 2012 and 2017? 
The purpose of this study was to examine the literature systematically to 
determine the accuracy, pros, and cons of assessment tools used for depression. The 
project also included basic lab test reports that could be used to rule out medical illnesses, 
which can present as depressed mood. To this extent, this project was a systematic review 
of the literature of published depression assessment tools and diagnostic tests for the 
treatment of depression in a primary care setting. The depression assessment tools were 
BDI, HDRS, and PHQ-2 and PHQ-9. Other depression assessment tools to be covered 




The management of depression lacks an easily accessible guide that can be used 
to rate the level of depression and rule out medical illnesses that resemble depression. Up 
to now, “Current psychiatric nursing practice remains grounded in tradition, unsystematic 
trial and error, and authority; although some of the wisdom that has been passed down 
over time is questionable, it continues to influence nursing practice today” 
(Zauszniewski, Bekhet, & Haberlein, 2012, p. 3). 
In Section 2 of this doctoral project, I address the background/context of the 
doctoral project, concepts, models, and theories, as well as the relevance of the doctoral 
topic to nursing practice, and I cite existing scholarship. The final report findings are a 
compilation of assessment tools and diagnostic tests for depression. 
Concepts, Models, and Theories 
In this DNP project, I used an appropriate nursing theory guided by the Walden 
University Manual for Systematic Review. The goal of this systematic review of the use 
of assessment inventory tools and diagnostic tests in the management of depression was 
to generate guidelines for best clinical practice. The identified problem was the lack of 
standardized instruments in some outpatient practices when caring for patients with the 
depression diagnosis. The goal was for clinicians to be able to use the product of this 
project as a guide to inform treatment and choice of depression inventory tools and 
diagnostic tests. Hence, in this project, I systematically reviewed existing literature and 
synthesized the findings concerning treatment and management of depression. 
I used Orlando’s nursing process theory (ONPT). ONPT was formulated by Ida 




guide for the nurse to use in the nursing process (i.e., assessment, diagnosis, planning, 
intervention, and evaluation) when caring for patients. Faust (2002) identified the 
purpose of the ONPT to include “encouraging the use of the deliberative process, 
improving the interaction between the nurse and patient, perception validation, and the 
use of the nursing process to produce positive outcomes or patient improvement” (p. 14). 
The primary element of this theory is that nurses should be able to provide 
“immediate explorations of patient’s perceptions, thoughts and feelings when ill” 
(Orlando, 1987, p. 405). This theory propagates that patients’ cries for help indicate a 
level of distress that can be analyzed and properly addressed by the nurses’ appropriate 
interventions. The patient’s presenting behavior might be a cry for help, yet, the patient’s 
needs may not be what they appear to be (Orlando, 1987). Because of this, nurses must 
use their perception, thoughts about perception, or the feeling engendered from their 
thoughts to explore the meanings of the patient’s behavior (Orlando, 1987). This process 
helps nurses determine the nature of the patient’s distress and provide the help he or she 
needs. The theory conceptualizes professional nursing functions, the process of nursing 
discipline, reactions that follow immediately, and improvements to the status quo 
(Orlando, 1987). 
Nursing process deals with the necessary steps to care for a patient starting with 
assessment, followed by diagnosis, planning, intervention, and evaluation. In the 1950s, 
nursing introduced a three-step process including observing, measuring and gathering 
data, and analyzing the findings (Doenges & Moorhouse, 2012). The first step of the 




concerns and health issues. The need for an accurate assessment is significant. An 
inaccurate assessment certainly results in incorrect overall nursing processes and adverse 
clinical outcomes. The major dimension of ONPT is that the nurse should inquire about 
patient concerns using appropriate tools or guidelines. The need for accurate assessment 
as identified by this theory is a reflection of the goal of this project. To conduct an 
accurate assessment, nurses need to use valid tools and their perceptions from interacting 
with patients and intuitions. The use of relevant tools improves communication between 
patients as well as providers, and it ensures accurate diagnosis and assessment of 
depression severity. 
Theories Related to Depression 
Concerning causes of depression, there are several theories proposed, and these 
relate to underlying causes of depression. These theories relate to neurotransmitter 
deficiencies such as serotonin (5-HT), norepinephrine (NE), and brain-derived 
neurotrophic factor, as well as stress. According to Lichtblau (2011), “Depression is due 
to a deficiency in some aspects of either NE or 5-HT activity in the brain” (p. 22). This 
theory also assumes stress can trigger interference with the gene that regulates a 
neurotrophic factor derived in the brain. The neurotrophic factor is a critical 
neurochemical that helps keep the neurons viable. It has also been described as “fertilizer 
for the brain cell” (Lichtblau, 2011, p. 22). In short, these theories are relevant to this 
topic, as the project addresses management of depression. 
Key terms 




• assessment tools: resources used to evaluate the incidence, occurrence, or severity 
of an illness; 
• depression: the state of being downcast or a state of severe sadness that can 
impair the patient’s level of functioning at work, school, or home; 
• diagnosis: the ability to make an assertion of an illness presented by a patient’s 
symptoms; 
• neurotransmitters: chemical messengers produced by neurons that allow carrying 
messages or signals from one neuron to another; 
• sensitivity: the ability of a tool to accurately test positive for an illness; sensitivity 
tests are used to rule out other diseases (i.e., the ability of the test to correctly 
identify those with the disease [true positive rate]); and 
• specificity: how often the test will be negative when the patient does not have the 
disease; specificity, in short, rules out those without the disease (true negative 
rate). 
Relevance to Nursing Practice 
In nursing practice, the need for accurate assessment when caring for patients is 
crucial. It demands emphasis and utmost attention because a misdiagnosis can commence 
from inaccurate assessment. Multiple health care organizations have in place 
recommendations concerning the use of evaluation tools in depressed patients. According 
to APA (2010), “there must be an assessment tool used for the initial diagnosis and 





The ability to manage any illness, medical or psychiatric, is vital. Evidence-based 
guidelines used for management of any diseases are available and most can be found 
online or in print form. The current state of nursing practice related to this issue is an 
inadequate diagnosis of patients with depression and lack of guidelines for the use of 
assessment tools and diagnostic tests in patients with depressed mood. According to 
Zauszniewski et al. (2012), “Psychiatric nursing is still very much tradition-based, with 
its accompanying trial and error and authority methods and yet this tradition continues in 
spite of the questions it has generated over the years” (p. 1). 
The tools necessary for an adequate diagnostic assessment of psychiatric illness 
include questionnaires, rating scales, standardized data forms, and structured interviews 
(APA, 2010). These instruments can be tools for diagnosis, parameters for measuring 
social or vocational functions, or for monitoring changes in severity of symptoms and the 
side effects of treatments. These instruments could also assist psychiatrists to ask the 
relevant questions during diagnostic interviews. The current state of nursing practice 
shows the use of assessment tools is not widespread in primary care settings 
(Zauszniewski et al., 2012). This gap-in-practice can be addressed with the use of 
appropriate tools and guidelines when managing patients with depression. 
Several national associations have advocated for the use of assessment tools in the 
management of depression. Current research data on new practices or tools for addressing 
the problem as identified in this project is minimal, and most literature still focuses on the 
use of assessment tools such as BDS and PHQ-9 assessment instruments. However, the 




line with the APA’s 2010 recommendation. The USPSTF (2016) recommends “screening 
for depression in the general adult population, including pregnant and postpartum 
women. Screening should be implemented with adequate systems in place to ensure 
accurate diagnosis, effective treatment, and appropriate follow-up” (p. 1). 
Depression can be a disabling illness, affecting patients irrespective of sex, race, 
ethnicity, financial circumstances, occupation, religious beliefs, or age. According to 
Bromet et al. (2011), “major depression is a severe, recurrent disorder linked to 
diminished role functioning and quality of life, medical morbidity, and mortality” (para. 
1). People dealing with depression often use descriptors such as: 
stressed out, unhappy, sad, melancholic, miserable, sorrowful, woeful, gloomy, 
despondent, hopeless, upset, tearful, in the dumps and having the doldrums. Other 
terms used for depression include low spirits, having a heavy heart, in despair, 
desolate, hopeless, upset, tearful, in the dumps, having the blues or in a funk. 
(Lichtblau, 2011, p. 22) 
With multiple words that can be used to describe this mental health issue and available 
treatment options, depression continues to be a major problem seen in primary care and is 
the fourth most common complaint encountered in such settings, which translates to 
approximately 1 in every 10 patients seen (Lichtblau, 2011). 
According to Uman (2011), “with an ever-increasing plethora of studies being 
published in the health studies, it is challenging if not impossible for busy clinicians and 
researchers alike to keep up with the literature” (p. 57). This doctoral project advances 




guidelines that shows the accuracy, pros, and cons of assessment tools and diagnostic 
tests in the management of depression. It is a resource tool to improve the standard of 
care or act as a guide in planning depression treatment protocol in the outpatient setting. 
According to Uman (2011), “reviews summarizing the outcomes of various interventions 
trials are an extremely efficient method for obtaining ‘the bottom line’ about what works 
and what does not” (p. 57). 
Depression Assessment Tools 
There is a summary of the assessment tools as appeared in this project. The 
depression assessment tools reviewed for this project included the following: BDI, 
HDRS, PHQ-2 and PHQ-9, MDI, SDS, and CES-D. 
Beck depression inventory. The BDI is a widely used scale created by Aaron T. 
Beck. Applicable to both clinical and non-clinical settings, BDI is known to be one of the 
most extensively researched and utilized self-report depression inventory scales 
(Campbell, Maynard, Roberti, & Emmanuel, 2012). A more modernized version, the 
BDI-II, is a 21-item self-rating tool designed for individuals from ages 13 and upward 
and can detect as well as measure level of depression severity. There are three versions of 
this scale—the original BDI, created in 1961, the revised BDI-1A from 1978, and the 
BDI-ll (Beck, Steer, & Brown, 1996). The BDI divides the components of depression 
into two subscales. One of them is the affective component, which affects the emotional 
state of mind. The second subscale consists of the physical (i.e., somatic) component, 
which affects the physical body. The reason for these seemingly unwarranted subscales is 




The two articles related to BDI chosen for this project are: 
Article 1. Campbell et al. (2012) compared the psychometric strengths of two 
depression assessment tools—Zung SDS and BDI-II. The sample size was 415 
undergraduate student volunteers with a mean average age of 25.2. The researchers’ goals 
include providing clinicians and scholars with information concerning the two depression 
tools and providing psychometric evidence concerning the tools’ reliability when used in 
patients with depression. The summary of findings for this article indicates the BDI-II 
demonstrated marginally superior internal consistency, reliability, and psychometric 
properties to the Zung SDS (Campbell et al., 2012). However, this article did not review 
sensitivity or specificity of the assessment tools. 
Article 2. Jakšić, Ivezić, Jokić-Begić, Surányi, and Stojanović-Špehar (2013) 
examined the diagnostic validity of BDI-II. The population size was 314 from a medical 
outpatient setting. Patients were notified of the project by their primary care provider, and 
the willing ones volunteered. The final finding from this article was that the BDI-II had a 
high sensitivity and high specificity rating with a satisfactory diagnostic validity in 
differentiating between healthy and depressed individuals in this setting (Jakšić et al., 
2013). The sample population used ranged from ages 25 to 87 with different acute 
illnesses, and I monitored them over a period of 2 months. One limitation of this article 
stems from the disclosure of intent of the survey to participants while there are no details 
about the non-willing population. 
Hamilton depression rating scale. In 1960, Max Hamilton developed this scale 




placebo (Zimmerman, Martinez, Young, Chelminski, & Dalrymple, 2013). In 1967, it 
was revised. Hamilton later created the Hamilton depression inventory and the Hamilton 
anxiety scale. The Hamilton depression scale (HAM-D) is a questionnaire consisting of 
17 to 21 items used to assess treatment response for patients previously identified with a 
depressive disorder. It differs from other scales since its use is the evaluation of a 
patient’s depression before, during, and after his or her personalized treatment. Estimated 
at 20 minutes, the scale is typically used by a clinician during the patient visit and 
depends mainly on the skill of the interviewer (Zimmerman et al., 2013). 
The two articles related to the Hamilton depression inventory are: 
Article 1. Raimo et al. (2015) carried out a study of psychometric properties of 
HDRS in multiple sclerosis. HDRS is a semi-structured interview consisting of 17 items 
assessing the whole spectrum of depressive symptoms, including affective, cognitive, and 
somatic symptoms. In this study were 100 patients among those who attended a multiple 
sclerosis center in a hospital setting. Other patients were excluded from the survey based 
on criteria such as general intellectual decline, as identified by age and education-
adjusted score lower than 23.8 on mini-mental state examination. In this study, selected 
ages were between 22-68 years with a mean of 43.3, with multiple sclerosis onset age at 
between 16-54 years. The educational year was between 5-19 years. The area under the 
curve was .988, which indicated the good discriminant power of the test. The achieved 
score of 14.5 provided the best tradeoff between sensitivity (93.33%) and specificity 




psychometric properties in assessing depression and, in this case, reliably tested patients 
with multiple sclerosis and depression. 
Article 2. Schneibel, Brakemeier, Wilbertz, Dykierek, Zobel, and Schramm 
(2012) carried out research entitled: Sensitivity to detect the change and the correlation of 
clinical factors with the HDRS and the BDI in depressed inpatients. The authors carried 
out a study of 105 hospitalized patients with mean age of 41.6 being managed for 
depressive disorder to determine the discrepancies and the potential prediction between 
HDRS and BDI to analyze their sensitivity to detect change. HDRS showed a superior 
sensitivity to change compared to BDI. This study was able to regard HDRS as two 
complementary rather than redundant or competing instruments, though, small sample 
sizes in the subgroups provided results that could not be generalized. Also, the reliability 
of the HDRS rating was obtained using independent interviews of the same subject. 
Patient Health Questionnaire. The PHQ-2 and PHQ-9 offer self-assessment 
tools in diagnosing depression. PHQ-2 is a two-question short assessment that can be 
used to screen for depression. The first two items of the PHQ-9, which question the 
degree to which a person has experienced anhedonia and depressed mood within the past 
2 weeks, make up the PHQ-2 assessment tool. Alternatively, the PHQ-9 is a nine-item 
questionnaire that provides the clinician or the client a tool to assess for depression. 
Article 1. Manea, Gilbody, and McMillan (2012) conducted a bivariate meta-
analysis on the optimal cutoff score for diagnosing depression using the PHQ-9 across a 
range of 18 studies. The study had a total of 7,180 participants with age ranging from 




MDD among the population selected. These authors recommended using the assessment 
tool in conjunction with other diagnostic criteria such as DSM-V or International 
Classification of Diseases-10 to make a diagnosis of depression, and the authors did not 
recommend the same cutoff score for all settings. 
Article 2. Manea et al. (2016) reviewed the use of the brief PHQ-2 in the 
assessment of depression in a clinical setting. PHQ-2 is used to assess two critical 
elements of depression: a loss of interest or pleasure or anhedonia and low mood. PHQ-2 
has been found to be very effective in the busy clinical setting due to the limited number 
of questions. Using bivariate diagnostic meta-analysis to derive sensitivity and 
specificity, the authors reviewed 21 studies with a total population of 11,175. The authors 
recommended reading the results of this test with caution because of the high risk of 
false-positive rate. The sensitivity at the cutoff mark of 2 is 0.91 and specificity 0.70. 
Composed of the first two questions of the PHQ-9, the PHQ-2 has been found to have a 
high accuracy level and continues to be a useful tool in screening for depression (Manea 
et al., 2016). 
Major Depression Inventory. MDI is a “self-report measure for depression 
based on the DSM-system” (Cuijpers, Dekker, Noteboom, Smits, & Peen, 2012, p. 1). 
This tool can be utilized by clinicians and health professions to diagnose and assess the 
severity of depression based on DSM-IV and ICD criteria. 
Article 1. Bech, Timmerby, Martiny, Lunde, and Soendergaard, (2015) carried out 
a study to evaluate the standardization of MDI as a tool for assessment of depression. I 




neuropsychiatric interviews had verified the diagnosis of DSM-IV major depression. 
MDI is a standardized tool for measuring depression with a cutoff score of 21, 26, and 31 
for mild depression, moderate depression, and severe depression respectively. From this 
article, the MDI assessment tool yielded a specificity of 82% and sensitivity of 90% for 
DSM-IV major depression. 
Article 2. Fawzi, Fawzi, and Abu-Hindi carried out this research in 2012. The 
basis was the Arabic version of the MDI as a diagnostic tool to test the reliability and 
concurrent validity among 50 Egyptians outpatients with MDD compared with 50 healthy 
Egyptians in the control group. Sensitivity was 88.4% while specificity was 78.9%. The 
study had excellent reliability and acceptable concurrent and discriminant validity. 
However, the shortcomings of this study included the small sample size, the individuals 
involved in the research were aware of the diagnosis of the participants, and the patient 
group consisted of only patients who met the diagnostic criteria for MDD. 
The Zung self-rating scale. Created by a psychiatrist from Duke University, 
named William W. K. Zung (as cited in Romera, Delgado-Cohen, Perez, Caballero, & 
Gilaberte, 2008), the Zung self-rating scale provides patients the opportunity to “self-
rate” their level of depression. The test is composed of 30 items that judge patients’ 
psychological and somatic depressive indications. The process consists of 10 positive and 
10 negative questions with each response noted on a scale of 1-4. At the end of the 
inquiries, the patient’s score is deposited between four ranges: 20-44 (normal), 45-59 
(mild depression), 60-69 (moderate depression), 70 and above (severe depression; 




Article 1. Campbell et al. (2012) conducted research with 415 students (75% 
female, 25% male, mean age 25.2 years) with a goal to compare the psychometric 
strengths of the Zung SDS and the BDI-II. The research also planned to provide 
researchers and clinicians interested in measures of depression with psychometric 
evidence that differentiated the two instruments in an academic setting. Though this study 
was not designed to evaluate specificity and sensitivity, it was able to make the following 
resounding conclusion that BDI-II demonstrated marginally superior internal consistency 
reliability (α = 0.88) than the Zung SDS (α = 0.85). Zung SDS was less psychometrically 
sufficient, and the wording was problematic. This study is a valuable tool in the 
assessment of adolescents and young adults in large treatment settings. The disadvantage 
of this study is it is limited to the sample size and cannot be generalized beyond the 
university settings. Also, the whole package of BDI-II is quite expensive for clinicians 
with limited resources. 
Article 2. Ruiz-Grosso et al. (2012) carried out a study of 70 patients in a clinical 
setting to validate the Spanish version of ZSDS. The accuracy of the tool regarding 
sensitivity and specificity is as follows: The cutoff scores for the highest proportions of 
correctly classified individuals among the major depressive episode with evidence of 
other psychiatric disorders (OPD) was ≥ 47, sensitivity = 85.7%, specificity = 71.4%. 
However, a major depressive episode with no evidence of psychiatric disorders was ≥ 45, 
sensitivity = 91.4%, specificity = 91.8%. This study revealed the ZSDZ including the 
Spanish version to be a valid assessment tool to diagnose depression in medical settings. 




Center for Epidemiological Studies Depression Scale (CES-D). This is a tool 
used for the general population to assess recent onset of depression. According to 
VanDam and Earleywine (2011), “CES-D is a popular assessment tool that has wide 
applicability in the general population with the goal to reflect modern diagnostic criteria 
and improve upon psychometric limitations of its predecessor” (para. 1). The CES-D 
questionnaire has 20 questions with a possible score of 0-60 points with a score of 16 or 
over indicative of depressed mood. 
Article 1. Chin, Choi, Chan, and Wong (2015) conducted research with 3,686 
Chinese adult primary care patients. CES-D was sensitive in detecting the area under the 
curve > 0.7. The CES-D showed to be a valid, reliable, sensitive, and responsive 
instrument for screening and monitoring depressive symptoms in adults. Cross-cultural 
comparisons of depression in multi-center studies also support this instrument. 
Article 2. Levine (2013) carried out a study to evaluate a seven-item CES-D short 
form (SF) using data from the National Longitudinal Survey of Youth. The participants in 
the 20-item CES-D questionnaire were as follows: (n = 8858) in 1992, to the 7-item CES-
D in 1994 (n = 8500) and from 1998 to 2010 if aged 40 (n = 7072) or 50 (n = 1574) or 
over. Regarding the reliability of the two versions of the CES-D, “a CES-D-SF cutoff 
score ≥ 8 had acceptable specificity (0.97, 95% CI 0.96, 0.97) and modest sensitivity 
(0.69, 95% CI 0.67, 0.71) with the standard CES-D cutoff score of 16” (Levine, 2013, p. 




Local Background and Context 
APA (2010) recommended the integration of measurement into psychiatric 
management. There is a need to use appropriate measures such as assessment tools and 
diagnostic tests when managing patients with depression in an outpatient setting. The use 
of routine assessments of patients with depressive symptoms in clinical practice can help 
provider evaluate the progress of depression and can facilitate cooperation and 
communication between the provider and patients.  
Local background of the topic stems from the lack of use of assessment tools in 
some outpatient behavioral health clinical settings (Okonofua, 2017). In these settings, 
patients are simply asked to assess the level of their depression using a verbal self-rating 
technique similar to pain scale assessment. However, this could be a problem. Therefore, 
health professionals should implement better assessment tools in the outpatient setting. 
APA (2010) suggested clinicians should integrate rating scales into the initial and 
ongoing evaluation. The identification and urgent treatment of depression is a local, 
national, and global issue addressed by national and international. Hence, the need for 
rapid diagnosis and subsequent treatment necessary to mitigate the negative effects of 
depression is imperative (NIMH, 2008). 
Role of the DNP Student 
The doctorate of nursing practice degree is one that prepares advanced practice 
nurse clinicians with the skill set necessary to apply evidence-based resources to solve 
practice problems and implement better health care models. The DNP clinician is also 




practices in assessing, diagnosing, and treating patients with illnesses and most 
especially, can help shape the best health care practices. The DNP program is such that it 
develops the necessary competencies in the student. This project helped develop my 
competencies as an expert nurse practitioner in behavioral health and assisted me in 
evaluating the quality of health care services. This project also provided the avenue to 
highlight deficiencies in the use of assessment tools in the management of patients with a 
diagnosis of depression. 
As a doctorate in nursing practice student, one of my professional goals is to 
contribute to the nursing profession. This doctoral project was a training avenue for me to 
perfect my scholarship skill set and provide contributions that are useful for managing 
patients with a diagnosis of depression. My role in this project was that of the author and 
researcher. This doctoral project was a systematic review of existing literature concerning 
the management of depression. Hence, the project had no participants or experiments and 
utilized high-quality resources that were relevant to the topic. 
The writer’s motivation for this doctoral project stemmed from personal 
experiences where thorough workups of patients with depressed mood have led to 
different diagnoses and treatment. Multiple health issues such as hormonal imbalance 
mimic depression; therefore, using appropriate tools for assessment and relevant 
guidelines to rule out medical problems was important. As an advanced practice nurse 
working in psychiatry, it is common to meet patients being treated for depression though 
their problem is a different health issue. Treating patients with an incorrect diagnosis can 




The use of assessment tools in managing depression is very important, and for this 
project, several biases within existing literature were possible. According to APA (2010), 
one may encounter biases related to culture, ethnicity, gender, society, and age when one 
uses an assessment tool or interprets the results. This DNP student reviewed the literature 
for any identifiable biases and issues that could affect the results compiled and identified 
no potential personal biases. 
Role of the Project Team 
This project was a systematic review of the literature and consisted of no project 
team. This DNP student was responsible for the topic, the plan of conducting the 
literature search, compilation of findings, and final submission of doctoral write-up. The 
committee chair and members contributed their expert opinions and guidance toward 
completion of this project. 
Summary 
The gap-in-practice as identified by this doctoral project was one that deserved 
adequate attention from health care professionals and clinicians. It is important to note 
the primary ingredient of diagnosis cannot be assessment tools. According to APA.org 
(2010), “clinical impressions of treatment response should consider the relative 
importance of specific symptoms to the patient’s function and well-being and the relative 
effects of specific symptoms on the patient’s social environment” (p. 3). Hence, “rating 
scales should never be used alone to establish a diagnosis or clinical treatment plan; they 
can augment but not supplant the clinician’s evaluation, narrative, and clinical judgment” 




relevance of the project to nursing practice, local background and context, and the role of 
the DNP student and project team. The next section focuses on collection and analysis of 
evidence as identified in the literature, the sources of evidence and strategies for analysis, 




Section 3: Collection and Analysis Evidence 
Introduction 
The purpose of this study was to examine the literature systematically to 
determine the accuracy, pros, and cons of assessment tools used for depression. The 
project also included basic laboratory tests report that could be used to rule out medical 
illnesses that can present as depressed mood. Hence, this DNP project was a systematic 
review of the literature of published articles related to depression assessment tools and 
diagnostic tests for the treatment of depression in a primary care setting. The depression 
assessment tools reviewed were BDI, HDRS, PHQ- 2 and PHQ-9, MDI, Zung SDS, and 
CES-D. 
The previous sections dealt with the project introduction, problem statement, 
purpose of the doctoral project, and nature of the project. I also reviewed the significance 
of the project, the applicable theories, the relevance to nursing practice, local background 
and context, the role of the DNP student, and the project team. Section 3 deals with 
collection and analysis of evidence as identified in the literature, the sources of evidence 
and strategies for analysis, and synthesis of evidence collated. 
Practice-Focused Question 
I reviewed existing literature for depression assessment tools identified earlier for 
their accuracy in terms specificity and sensitivity, advantages and disadvantages, 
demographics of patients, and the health care settings. I also listed diagnostic tests that 
could be performed to rule out medical illnesses that mimic depression. The final product 




The practice-focused question was: What are the characteristics and indications of 
the major depression screening tools published in peer-reviewed literature between 2012 
and 2017? 
There is an existing gap-in-practice whereby management of depression lacks an 
easily accessible guide that can be used to rate the level of depression and rule out 
medical illnesses that resemble depression. The findings of this doctoral project could 
contribute to the gap-in-practice. The compilation of the depression assessment tools in a 
tabular form make it readily available for health care professionals, clinicians, patients, 
and family members to read and use for management of depression. Zauszniewski et al. 
(2012) explained that current psychiatric nursing practice is still grounded in tradition, 
nonsystematic trial and error, and wisdom that are passed on over time. 
In this section of the project, I review the sources of evidence, analysis, and 
synthesis of the research findings, and I identify the systems used for recording, tracking, 
organizing, and analyzing the evidence. I also report on the methods used to ensure the 
integrity of results and a summary emphasizing the key points of this section. 
Sources of Evidence 
The need to have a more accurate, detailed, and exhaustive search led me to use 
the following databases in this order until I found relevant articles: Cochrane Database of 
Systematic Reviews, MEDLINE PLUS CINAHL database, and then Google Scholar 
database, all retrieved from Walden University Library. I verified relevant articles I found 





I searched for appropriate articles published from 2012 to 2017 using the 
following keywords: BDI, HDRS, PHQ, major depression literature, Zung self-rating 
scale, Center for Epidemiologic Studies, outpatient, clinic, specificity, sensitivity, 
psychometric, accuracy, and validity. I excluded other depression assessment tools such 
as the geriatric depression scale and the Cornell scale for depression in dementia, and I 
also excluded populations younger than 18 years. I made exceptions for articles 
concerned with ages older than 50 years if the age range of participants included ages 
younger than 50 years.  
I appraised the articles using the Melynk Critical Appraisal Guide, which lists 
seven steps that can be used to critically appraise quantitative studies. The list below 
shows the seven questions that were answered from the Critical Appraisal Guide for 
Quantitative Studies for each article reviewed: 
1. Why was the study done? • Was there a clear explanation of the purpose of the 
study and, if so, what was it? 
2. What is the sample size? • Were there enough people in the study to establish that 
the findings did not occur by chance? 
3. Are the instruments of the major variables valid and reliable? • How were 
variables defined? Were the instruments designed to measure a concept valid (did 
they measure what the researchers said they measured)? Were they reliable (did 




4. How were the data analyzed? • What statistics were used to determine if the 
purpose of the study was achieved? 
5. Were there any untoward events during the study? • Did people leave the study 
and, if so, was there something special about them? 
6. How do the results fit with previous research in the area? • Did the researchers 
base their work on a thorough literature review? 
7. What does this research mean for clinical practice? • Is the study purpose an 
important clinical issue? (Stillwell et al., 2010) 
While reading the articles and answering the questions I have outlined, I sorted 
the articles into relevant and nonrelevant stacks. From the relevant stack of articles, I 
used Bandolier’s hierarchy levels of evidence to choose two articles that met the criteria 
for level one, which was the highest level of evidence-based research available: 
systematic reviews and meta-analysis (Mantzoukas, 2008). This search strategy ensured 
the highest quality of evidence was selected first from the Cochrane Database for 
Systematic Review articles followed by articles from peer-reviewed journals in the other 
databases. 
From the compiled resources, the writer hoped to find answers to the questions as 
identified in the project question which was: What are the characteristics and indications 
of the major depression screening tools published in peer-reviewed literature between 
2012 and 2017? 
The evidence collated from the articles concerning depression assessment tools 




information concerning the accuracy, advantages, and disadvantages to have a better 
understanding of the settings where health care professionals could utilize these tools, 
and to provide answers to the research question in this project. 
Published Outcomes and Research 
This project was a systematic review of existing literature concerning the use of 
appropriate tools for management of depression in an outpatient setting. A systematic 
review was less biased when compared with narrative reviews. According to Uman 
(2011), “systematic reviews, as the name implies, typically involve a detailed and 
comprehensive plan and search strategy derived prior, with the goal of reducing bias by 
identifying, appraising, and synthesizing all relevant studies on a topic ” (p. 57). 
By using relevant keywords, developing a search strategy, and using a reference 
librarian to help in conducting searches, the search was expected to be exhaustive and 
comprehensive. To ensure authenticity of the project results, the writer reviewed existing 
studies that showed the use of depression tools in adult patients from ages 18 to 50 years, 
relevant keywords (e.g., the different depression inventory tools, specificity, sensitivity, 
validity, reliability), meticulously organized data extracted into an easy to use format, and 
stored the results of the project within a secured database. To ensure the objectivity of 
compiled data, the researcher reviewed any biases and reviewed the statistical data (e.g., 
sensitivity, specificity, reliability, and validity) as presented in the articles. 
Evidence Generated for the Doctoral Project 
Participants. Three members were involved in reviewing the evidence as 




and provided their opinion anonymously. These participants were volunteers and worked 
as a psychiatrist, nurse practitioner, or psychologist at the contracted clinical site. Based 
on their professional expertise, these professionals were conversant with the process of 
diagnosing patients with symptoms of depression and use of the different depression 
assessment tools. 
Procedures. Upon completion of the feedback stage, the researcher presented the 
findings as a PowerPoint presentation to management at the clinical site. The overall goal 
was to develop a clinical guideline for diagnosing depression, which could be utilized by 
new and existing providers. I compiled the data from this project into an Excel 
spreadsheet showing the results (type of literature—systematic review [high-quality 
evidence] or peer-reviewed articles [moderate-quality evidence], the number of 
participants, the age of participants, specificity, sensitivity, advantages, and 
disadvantages of the depression inventory tools). An additional tool showing laboratory 
tests to rule out illnesses that mimic depression was presented in Appendix G of this 
project and referenced within the manuscript). This laboratory test tool was generated 
using existing textbooks. The different depression instruments were attached as 
Appendices A-F of the project as well. 
Protections. I presented the expert panelists with a disclosure form concerning 
their role, questionnaire procedures, voluntary nature of the project, risks and benefits of 
being in the project, and privacy and their rights concerning the project as well as the 
topic, practice-focused questions, and Walden University’s advocate phone number in 




ensured approval by Walden University institutional review board before engaging with 
the expert panelists, and provided the expert panelists with an ethics approval number in 
case they needed to contact the university. The expert panelists signed the form stating an 
understanding of their role before reviewing the evidence presented in the project and 
were allowed to withdraw from the project at any point. The expert panelists and 
participating organization identity were masked and were not shared or printed on the 
project. The questionnaires completed by the expert panelists will be stored safely for 2 
years after the publication of this project in accordance with Walden University 
guidelines. 
Analysis and Synthesis 
I entered the information retrieved concerning the different depression assessment 
tools into a Microsoft Excel spreadsheet. The findings of this report are in tabular form 
with several headings such as depression assessment tools, the number of articles 
reviewed, and accuracy of the tools regarding sensitivity, specificity, age groups, and 
demographics. Another heading was the type of health care setting for the assessment 
tool and advantages and disadvantages of the assessment tools as identified from existing 
literature. The findings were a detailed compilation of all articles. 
To ensure the integrity of information collated, the writer utilized high-quality, 
peer-reviewed articles. I reviewed multiple articles and used the most appropriate two 




This project was a systematic review of existing literature concerning the use of 
the indicated depression assessment tool. I presented a summary of all the articles in 
tabular form in the conclusion. I performed no data analysis on the statistical data used. 
Summary 
Depressive disorders in medical settings remain under-recognized even though 
associated with high cost and disability expense (Manea et al., 2016). The CDC (2017) 
estimated the economic burden of depression, which includes suicide, and workplace 
related and direct costs, to be $210.5 billion in 2010. CDC (2017) linked depression to 
increased mortality risks, medical illnesses such as heart disease, and employment-related 
problems such as lower workplace productivity and absenteeism. 
This section is a compilation of the sources of evidence, analysis, and synthesis of 
the research findings. I reviewed the systems used for recording, tracking, organizing, 
and analyzing the evidence as well as methods to ensure the integrity of findings. The 




Section 4: Findings and Recommendations 
Introduction 
Local background of the topic stems from the lack of use of assessment tools in 
some outpatient behavioral health clinical settings (Okonofua, 2017). In such outpatient 
settings, patients are simply asked to assess the level of their depression using a verbal 
self-rating technique similar to pain scale assessment. The gap-in-practice is the lack of 
use of objective depression assessment tools in diagnosis and management of depression 
in some health care settings. Therefore, I systematically reviewed existing literature and 
compiled information on accuracy, pros, and cons of different depression inventory tools 
and diagnostic tests for management of depression with the goal of improving quality of 
care provided to patients by clinicians. The practice-focused question was: What are the 
characteristics and indications of the major depression screening tools and diagnostic 
tests published in peer-reviewed literature between 2012 and 2017 for adult patients? 
In this section of the project, I lay out the systematic search of the literature 
concerning psychometric properties of six depression inventory tools. Within this section, 
I include the findings, implications for nursing/social change, recommendations made for 
the clinical site with noted practice deficiencies, strength, and limitations of the project. 
The six depression tools were as follows: BDI, HDRS, PHQ-2 and PHQ-9, MDI, SDS, 
and CES-D. 
I performed the search for appropriate articles using the following keywords: BDI, 
HDRS, PHQ, major depression literature, Zung self-rating scale, Center for 




and validity. The articles selected were published between 2012 and 2017, with 
participants between ages 18 and 50 years and the article’s goal of reviewing 
psychometric properties of any of the included depression assessment tools. The need to 
have a more accurate, detailed, and exhaustive search led to the use of the following 
databases in this order to find relevant articles: Cochrane Database of Systematic 
Reviews, MEDLINE PLUS CINAHL database, and then Google Scholar database, all 
retrieved from the Walden University Library. Relevant articles found in Google Scholar 
were verified in the Ulrich Periodical Directory to ensure they were peer-reviewed. 
Inclusion Criteria 
The studies used included literature that met all of the following criteria: (a) 
reviewed the psychometric properties of any of the six depression assessment tools; (b) 
published between 2012 and 2017; and (c) age of participants between 18 and 50 years. 
There were no restrictions to geographical location. The inclusion criteria consisted of 
whether the article was a systematic review of the literature (or peer-reviewed articles if 
there was no systematic review of literature article after exhaustive search in the multiple 
databases or search engines). 
Exclusion Criteria 
I excluded other depression assessment tools such as the geriatric depression scale 
and Cornell scale for depression in dementia. This project mainly addressed articles 
covering the aforementioned six depression inventory tools with population from ages 18 
to 50 years. Exceptions included articles with the population older than 50 years when the 





Overall, 10 articles based on the inclusion and exclusion criteria were reviewed 
for this project, whereas some of the articles covered more than one depression 
assessment tool. Even though my goal was to use articles of the highest quality 
(systematic review of literature), of the 10 articles selected, only one article was a 
systematic review of the literature, whereas the other articles were peer-reviewed articles 
of high quality. 
Analytical Strategies Used 
The results of a systematic review of the literature concerning the six depression 
assessment tools are in tabular form for readers’ easy reference. Addressing an aspect of 
the practice-focused question, Table 1 and Table 2 show the sensitivity and specificity of 
the depression assessment tools, which help readers to understand the reliability, 
accuracy, and validity of the tools. These first two tables consist of the sensitivity and 
specificity of the tools ranked from the least to the highest. Table I1 (Appendix I) is a 
compilation of the age groups or demographics, the advantages, disadvantages, cutoff 
scores, cost, and direct references to the depression assessment tools. Table I2 (Appendix 
I) provides additional information regarding study design, methods, level of evidence, 
setting, country, number of participants, and the outcomes of the studies. 
Findings and Implication 
Presently, only a few systematic literature reviews address psychometric 
properties of depression inventory tools. Of the 10 articles selected for this project, only 1 




and indications of the major depression screening tools and diagnostic tests published 
mostly in peer-reviewed literature between 2012 and 2017 found in the Cochrane 
Database of Systematic Reviews, MEDLINE PLUS CINAHL database, and Google 
Scholar database. 
Accuracy of the Depression Assessment Tools 
I reviewed the accuracy of the depression assessment tools using their sensitivity 
and specificity ratings from the different articles selected. 
Sensitivity of the Six Depression Assessment Tools 
Sensitivity refers to the ability of a tool to accurately test positive for an illness. 
Sensitivity tests are used to rule out other diseases (i.e., the ability of the test to correctly 
identify those with the disease [true positive rate]). Arranged from the least to the most 
sensitive, PHQ2 was identified as 83% sensitive, BDI-II at 85%, PHQ-9 at 88%, Zung’s 
SDS from 85.7% to 91.4%, and MDI from 88.4% to 90%. HDRS has the highest ranking 
with 93%. From this analysis, evidence shows all six depression assessment tools have a 
high sensitivity rating from 83% to 93%. 
Table 1 
Sensitivity of the Six Depression Assessment Tools 









Sensitivity 83 85, 85 88 91.4 88.4, 90 93* * 
Note. *Not available. Values for the depression tools were extrapolated from each article reviewed (see Appendix H). 
Specificity of the Six Depression Assessment Tools 
For specificity, the question was: How often will the test be negative when the 




(true negative rate). Arranged in order from the least specific to the most specific, Table 2 
shows MDI as on average (82%, 78.9%) the least specific rating while HDRS has the 
highest specific rating at 97%. 
Table 2 
Specificity of the Six Depression Assessment Tools 
 MDI Beck’s 
depression 
inventory-II 






Sensitivity 82, 78.9 78, 88 88 90 91.8 *97 * 
Note. *Not available. Values for the depression tools were extrapolated from each article reviewed (see Appendix 
H). 
From the analysis of Tables 1 and 2, evidence shows HDRS to have the highest 
sensitivity (93%) and specificity (97%) rates. Overall, all six depression rating scales 
exhibit high ratings on both the specificity (range from 83% to 93%) and sensitivity rate 
ranging from 78% to 97% (except CES-D that did not include the sensitivity or 
specificity on either of the articles reviewed). From these data, the writer believed the 
choice of any of the depression tools was valid and based on clinician preference and 
factors such as the pros and cons, as well as availability or cost of the tools. 
To further answer the practice-focused questions for this project, Table I1 in 
Appendix I contains essential data such as the pros and cons as well as whether the tools 
are in public domain or are proprietary. The table answered part of the practice question, 
which was: What are the characteristics and indications of the major depression screening 
tools and diagnostic tests published in peer-reviewed literature between 2012 and 2017 
for adult patients?  Therefore, the table includes findings such as the age groups for the 
use of the depression assessment tools, type of health care settings, advantages, and 




such as cutoff scores for the depression inventory tools, their costs, and reference to the 
publisher or reliable sites where these depression assessment tools can be found for 
purchase or free use. 
Other Findings from Analysis and Synthesis of the Collected Evidence 
The articles utilized for this project were evaluated using the Critical Appraisal 
Guide for Quantitative Studies, and all of the articles met all seven steps of this guide. 
There was a clear explanation of the purpose of the studies; the sample size identified 
ranged from 70 participants in 1 study to 8500 participants in another study. There was an 
explanation of the major variables and the instruments measured the relevant concepts 
showing reliability and validity of the depression inventory tools. The statistical analyses 
were complex, using software such as SPSS and SAS. The articles identified any 
untoward events such as participants removed because of not meeting criteria for 
inclusion or questionnaires not included because of missing values. 
Thorough literature research was conducted in all the studies while the results fit 
previous research in their area. Some of the findings validated earlier findings of the 
assessment tools such as there was a strong correlation between some of the depression 
inventory tools. From one of the articles, there was a strong correlation between BDI and 
Zung SDS, but then BDI was found to have marginal superior internal consistency 
reliability (Alpha = 0.88) compared to Zung SDS (Alpha = 0.85; Campbell et al., 2012) 
Unanticipated Limitations and Their Potential Effects on the Findings 
Just as expected in any project, there were unanticipated limitations to this 




• After exhaustive searches, there were very few publications found that were of 
relevance to the project or that reviewed psychometric properties of depression 
inventory tools. 
• Even though many of the articles found were peer-reviewed, only a few were a 
systematic review of literature, which is the highest level of evidence this 
researcher sought. 
• Another unanticipated limitation was that some of the selected articles were a 
comparison of one depression tool with another in other countries such as Croatia, 
Italy, Germany, Denmark, and Barbados. 
• For the information needed to compile the above tables such as the age of patients 
who could use the assessment tools, there were no results in the articles; the 
results were on publisher websites. 
• There were variations in specificity and sensitivity of the PHQ-9 at different 
cutoff scores. For instance, the research findings from Manea et al. (2012) 
indicated a variation in sensitivity and specificity at different cutoff scores. 
Hence, the question arises: At what cutoff point are some of the tools indicative of 
depressed mood?  For PHQ-9, for instance, Manea et al. (2012) concluded it had 
acceptable diagnostic properties at a range of cutoff scores (8-11). Therefore, 
when using PHQ-9, clinicians should exercise caution when choosing a cutoff 
score by “taking into account the characteristics of the population, the settings and 
the efficacy of screening on outcomes” (Manea et al., 2012, p. 195). These 




negatives in hospital settings while more false-positive results may be seen in 
primary care” (Manea et al., 2012, p. 195). 
• Limitation of analysis in articles: Bech et al. (2015) used a time frame that 
covered the past week and not the conventional 2-week time frame for diagnosis 
of depression. 
• Completed data were not available in some of the included information while in 
some of the articles, there were missing values from the assessment completed by 
the patient. 
• The potential effect of these limitations is difficult to determine based on the 
strengths of the articles. The articles were thorough in their literature search, data 
compilation, and data analyses and provided enough information to support the 
summaries and recommendations made to the clinical site with noted practice 
deficiency. 
Implications of Findings Regarding Individuals, Communities, Institutions, and 
Systems 
The implications resulting from the findings show specific assessment tools as 
having high reliability, sensitivity, and specificity when compared to others. At the 
individual level, the findings indicated the depression assessment tools could reliably be 
used to determine individuals’ level of depression based on clinicians’ preferences. At the 
community, institution, and systems levels, it is essential for the clinician to know factors 
that can affect the results of both self-reported and observer-related depression inventory 




and “can be affected by demographics, clinical characteristics of patients such as age, 
level of education, type or depression and personality type” (Schneibel et al., 2012, p. 
63). For the observer-related assessment tools, it is essential to note an observer could be 
more likely to see improvements in depressive symptomatology than a patient, and the 
patient may still be affected by cognitive bias (Schneibel et al. 2012). 
For PHQ-2, the meta-analysis research conducted by Manea et al. (2016) 
suggested the possibility of inaccuracy in the cutoff score detecting patients with 
depression and the authors suggested lowering the cutoff from three. At a cutoff score of 
two, there is increased sensitivity. This variation in researched sensitivity of the PHQ-2 
compared with the original validation study with a cutoff of three shows the need for 
further research into this issue in the future. 
Potential Implications for Positive Social Change 
The implication for positive social change includes the fact that the findings of 
this project could be used by clinicians to determine their choice of depression 
assessment tools. Researchers, likewise, could use this project for a quick overview of 
existing publications about the various depression assessment tools addressed within this 
project. In essence, this project could lead to increased use of depression assessment tools 
and improved diagnosis and management of depressed mood among patients in any 
health care settings from outpatient to inpatient. This project also shows the need for 
objective depression tool usage is a worldwide phenomenon and so the usability of the 
findings of this project extends beyond the boundaries of the United States and has the 





The gap-in-practice is the lack of use of objective depression assessment tools 
in diagnosis and management of depression in some health care settings, my clinical site 
inclusive. Multiple barriers contributing to this problem can be seen at the macro and 
micro level. At the macro level globally, World Health Organization (2008) identified 
lack of resources (some of the depression assessment tools are not in public domain and 
cost money), lack of trained health care providers, and the social stigma associated with 
mental disorders as barriers to patients being treated adequately using the depression 
tools. Within the clinical settings, obstacles include time constraints and inherent 
resistance to change by integrating depression tools into the business process by clinical 
staff and providers. At the micro level, patients’ resistance to seeking treatment, 
resistance in completing assessment tools, inaccurate report of the severity of depression 
by patients, erroneous information provided on the assessment tools, and fear of 
“depression” stigma are some of the barriers to the use of assessment tools (Okonofua, 
2017). These obstacles at the micro and micro levels could be challenges to the full 
implementation of these evidence-based guidelines in the use of depression assessment 
tools in outpatient settings (Okonofua, 2017). The following were the recommendations 
made for my clinical site where the use of depression assessment tools was very minimal. 
Depression inventory tools are an essential part of objectively assessing a 
patient’s mood in a health care setting. Therefore, the recommendations I made to the 
clinical practice setting (where I did my clinical rotation and noticed lack of use of 




• Choose a depression inventory tool based on its accuracy and reliability. 
• Train clinicians and office personnel on the importance of using such objective 
tools to screen for or to assess a patient’s level of depression. 
• Develop and implement a quality improvement plan by inculcating the preferred 
depression assessment tool in electronic form into the electronic health records 
systems or integrated within a facility website whereby patients could complete 
the tests from any location and results would be readily available to the health 
care provider before a patient’s visit. 
• If patients are unable to complete the online assessment tools, integrate the 
depression assessment tools into business processes and allow patients to 
complete the tests while waiting to be seen by the providers either in paper form 
or on iPad, so that results are easily available to the provider. 
• Implement the compulsory use of evidence-based practice resources such as the 
depression assessment tools into the organization policies and procedures for 
patient care. 
• Encourage patients’ involvement and improve patients’ understanding of the 
assessment tools used in psychiatry. 
• If clinical practice is not utilizing any depression assessment tools currently, 
formulate and implement a plan for the change of process within the facility. 
Proposed Secondary Products to Guide the use of the Primary Products in Practice 
The six depression inventory tools’ cutoff scores for detecting depressed 




these copies are for educational purposes, users of the product of this project should 
ensure they do not violate copyright of any depression assessment tools by simply 
copying the tools from this project. A compilation of the publications reviewed for this 
project is provided in Appendix H.  
Contribution of the Doctoral Project Team 
While this project utilized no project team members, the products of this project 
would not have been possible without the valuable inputs of the chair and members of the 
committee. At this time, there are no plans to extend this project beyond the DNP 
doctoral project. 
Strengths and Limitations of the Project 
This project was a comprehensive systematic review of existing literature about 
psychometric properties of the six depression assessment tools. Ten high-quality peer-
reviewed and systematic review of literature articles were reviewed and analyzed. A 
significant strength of this project was that very marginal variability was noted 
concerning the reliability and validity of the depression assessment tools from the various 
articles reviewed. The samples used for the articles, their data gathering, and analysis 
indicated minimal bias or limitations. The articles used were dispersed geographically, 
showing the question about psychometric properties of depression assessment tools 
covers multiple countries and continents. 
The limitations of the project included, first, there was very little work on the 
topic. Second, there were some identified biases in some of the articles. For example, in 




patients identified as depressed in some of the articles did not undergo further 
confirmatory testing, which meant these works had partial verification bias. 
Recommendations for Future Projects Addressing Similar Topics with Similar 
Methods 
The findings from this project show very little work completed concerning the 
psychometric properties of depression assessment tools. Hence, this author encourages 
future work should be conducted by clinicians, most especially health care professionals 
in advanced nursing roles. Authors of future studies regarding psychometric properties of 
the depression tools should consider reporting on the different tools as well as any 




Section 5: Dissemination Plan 
DNP-prepared nurses encounter stages in their projects when they must 
disseminate the findings and implications. It is essential to spread evidence-based 
practice findings to key stakeholders, organizations, and other health care professionals to 
use the recommendations and innovations for practice in different settings (Forsyth, 
Wright, Scherb, & Gaspar, 2010, p. 2). The presentation of findings to key stakeholders is 
essential in any evidence-based project or research. According to Forsyth et al. (2010), to 
“facilitate timely and quality dissemination of evidence-based practice projects, there is a 
need for clear criteria identifying the essential information to be shared, how to share it 
effectively, and how to evaluate the end product” (p. 2). 
On completion of this systematic review of the literature concerning the use of 
depression assessment tools, I provided the findings to the clinical setting as an 
educational session with the hope of health care professionals using the recommendations 
in the management of a depression diagnosis. I conducted an oral presentation by using 
technology such as projectors and PowerPoint slides. The oral presentation afforded me 
the opportunity to interact with the key stakeholders, to clarify any issues, and to receive 
feedback. The tactfulness and professionalism of the presenter played a significant role in 
presentation of the project findings. In short, I presented this DNP project, the findings, 
and recommendations as an oral presentation to my clinical site. 
Based on the nature of this project, other audiences such as advanced nurse 
practitioners, psychiatrists, and psychologists in private practices, community-based 




project. A poster presentation is another form by which I could present the findings in 
these settings or at professional workshops. However, there are key elements in poster 
development and presentation of which the presenter must be aware. These elements 
include the following: 
• early planning with a clear focus; 
• following conference guidelines, such as poster size and type (hanging or 
freestanding); 
• using bullet points or abbreviated wording; 
• incorporating pictures or graphics; 
• balancing content with white space; and 
• using a large font size for viewing at a distance. (Forsyth et al., 2010, p. 2) 
Analysis of Self 
The DNP education journey has prepared me to be a better nurse leader with the 
ability to discern issues that can influence patient outcomes. The preparation for my DNP 
project, the choice of topic, and the process of engaging with my committee chair and 
committee members have made me a better nurse leader, scholar, writer, and most 
especially, an advocate for better patient care. 
As a nurse practitioner in behavioral health, my passion is in caring for patients 
with mental health disorders. Hence, for future goals, I intend to seek out opportunities to 
disseminate the findings of this project through various professional organizations, 




articles in health-care-related journals. My other goals include seeking out opportunities 
for psychiatric nursing instruction at graduate and undergraduate levels. 
My DNP education at Walden University has prepared me for future professional 
roles as a nurse leader. As a nurse practitioner, it has sharpened my knowledge of the 
need to provide evidence-based care to improve health outcomes and to be an advocate 
for improved patient care within organizations. My DNP education has instilled in me the 
values of a health care leader, the “eyes of a change agent,” and the passion for leaving a 
mark as a health care leader that can bring about social change at micro and macro levels. 
My goal is to continue in my professional path by seeking opportunities in academia, 
within my organization, in my community, and at international levels to be a change 
agent and to have a positive influence on health care and the lives of people. 
Summary 
Depression is a mental illness requiring prompt identification and treatment 
because it has grave consequences if untreated. Depression can affect a person’s level of 
functioning, can lead to worsening health conditions and comorbid substance abuse, and 
can lead to suicide at its worst. Hence, the need to accurately diagnose and treat patients 
with depression using assessment tools and diagnostic tests is critical. My chosen topic, 
use of assessment tools in the management of patients with depression, is an area that I 
am passionate about and I firmly believe every clinician should use objective assessment 
tools when caring for patients. By working on my DNP project, I discovered a few 
published articles of the highest quality of evidence (i.e., a systematic review of 




systematic literature review, I investigated six depression assessment tools regarding their 
accuracy (identified by specificity, sensitivity, reliability, and validity), their pros and 
cons, and the possible demographics and health care settings to use these inventory tools. 
The six depression inventory tools examined for his project included BDI, HDRS, PHQ-2 
and PHQ-9, MDI, Zung SDS, and CES-D. The practice-focused question was: What are 
the characteristics and indications of the major depression screening tools/diagnostic tests 
published in peer-reviewed literature between 2012 and 2017 for adult patients? Of the 
six depression assessment tools reviewed, HDRS was found to have the highest 
specificity and sensitivity. 
A major insight gained from this project and the journey of the DNP degree is that 
it takes a team to bring about a change. Although there were personal challenges along 
the way of this project, using the strength of my team, my chair, my colleagues, my 
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Appendix A: Beck Depression Inventory 
Beck Depression Inventory is a copyright protected assessment tool that cannot be 




Appendix B: Hamilton Depression Rating Scale 












































The Hamilton Depression Rating Scale is the most widely used interview scale, 
developed in 1960 to measure the severity of depression in an inpatient population. Since 
then, many versions have been adapted, including structured interview guides, self-report 
forms, and computerized versions. 
In the original clinician-administered scale, the first 17 items are tallied for the 
total score, while items 18-21 are used to further qualify the depression. The scale takes 
20-30 minutes to administer. Scores of 0-7 are considered normal, and scores greater than 
or equal to 20 indicate moderately severe depression. Each item either is scored on a 5-
point scale, representing absent, mild, moderate, or severe symptoms, or on a 3-point 
scale, representing absent, slight or doubtful, and clearly present symptoms. The HDRS 
contains a relatively large number of somatic symptoms and relatively few cognitive or 
affective symptoms. The 21 items it assesses are as follows: 
• Depressed mood 
• Feelings of guilt 
• Thoughts of suicide 
• Insomnia 
• Work and activities 
• Psychomotor retardation 
• Psychomotor agitation 
• Psychic anxiety 
• Somatic anxiety 
• Gastrointestinal symptoms 
• General somatic symptoms 
• Genital symptoms 
• Hypochondriasis 
• Loss of insight 
• Loss of weight 
• Diurnal variation 
• Depersonalization and derealization 
• Paranoid symptoms 
• Obsessional and compulsive symptoms 
 




Appendix C: PHQ-2/PHQ9 
PHQ-2 
Over the past two weeks, how often have you been bothered by 
any of the following problems? 
Little interest or pleasure in doing things. 
0 = Not at all 
1 = Several days 
2 = More than half the days 
3 = Nearly every day 
Feeling down, depressed, or hopeless. 
0 = Not at all 
1 = Several days 
2 = More than half the days 
3 = Nearly every day 





Probability of major depressive 
disorder(%) 
Probability of any 
depressive disorder(%) 
1 15.4 36.9 
2 21.1 48.3 
3 38.4 75.0 
4 45.5 81.2 
5 56.4 84.6 
6 78.6 92.9 
 
Source: Kroenke, K., Spitzer, R. L., & Williams, J. B. (2003). The Patient Health 






Appendix D: Major Depression Inventory 
 




Appendix E: Zung Self-Rating Depression Scale 
Instructions: For each item below, please place a check mark (√) in the column 
which best describes how often you felt or behaved this way during the past several days. 





of the time 
Most of the 
time 
1. I feel down-hearted and blue.     
2. Morning is when I feel the best.     
3. I have crying spells or feel like it.     
4. I have trouble sleeping at night.     
5. I eat as much as I used to.     
6. I still enjoy sex.     
7. I notice that I am losing weight.     
8. I have trouble with constipation.     
9. My heart beats faster than usual.     
10. I get tired for no reason.     
11. My mind is as clear as it used to be.     
12. I find it easy to do the things I used to.     
13. I am restless and can’t keep still.     
14. I feel hopeful about the future.     
15. I am more irritable than usual.     
16. I find it easy to make decisions.     
17. I feel that I am useful and needed.     
18. My life is pretty full.     
19. I feel that others would be better off if I 
were dead. 
    
20. I still enjoy the things I used to do.     
Source: Zung, W. W. K. (1965). A self-rating scale for depression. Archives of General 




Scoring the Zung Self-Rating Depression Scale 
In scoring the SDS, a value of 1, 2, 3 and 4 is assigned to a response depending upon 
whether the item is worded positively or negatively. 
 
For items 1, 3, 4, 7, 8, 9, 10, 13, 15, 19 the scoring is: 
• A little of the time = 1 
• Some of the time = 2 
• Good part of the time = 3 
• Most of the time = 4 
 
Items 2, 5, 6, 11, 12, 14, 16, 17, 18, 20 are reverse scored as follows: 
• Most of the time = 1 
• Good part of the time = 2 
• Some of the time = 3 
• A little of the time = 4 
The SDS index is derived by dividing the sum of the values (raw scores) obtained on the 
20 items by the maximum possible score of 80 and expressed as a 
decimal point. The table below converts raw scores into SDS index scores. 
A Table for the Conversion of Self-Rated Raw Scores to the SDS Index 
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1
 Source: Zung, W. W. K. (1965). A self-rating scale for depression. Archives of General 




Appendix F: Center for Epidemiologic Studies Depression Scale (CES-D) 
 




Appendix G: Physical Sources, Medical Conditions, Medications, and Laboratory 
Screening Associated with Major Depressive Disorder 
Physical Sources Medical Conditions Laboratory Screening Medications 
Food allergies 
Hypoglycemia 















cancer and lung cancer) 
Cardiac conditions (e.g., 
congestive heart failure, 











disease, syphilis (late 


















calcium, phosphate, and 
magnesium levels) / vitamins 
(vitamin B12, Vit D) 
Liver and renal function tests 
(BUN, LFT) 
Rapid plasma regin -RPR 
(blood screening test for 
syphilis) 
Urinalysis 
Urine toxicology screen for 
drugs of abuse 
Serum alcohol level 
Urine pregnancy test 
HIV serology 
































Not recommended due to 
little justification for their 
use in routine screening for 
psychiatric illness and 
limited in identifying 
medical causes of psychiatric 
disorders 
Computed tomography 
Magnetic resonance imaging 
Sources: Perese, E. F. (2012). Psychiatric Advanced Practice Nursing: A Biopsychosocial Foundation for 





Appendix H: Compilation of the Eight Publications Reviewed for This Project. 
Depression 
Diagnostic Tool 
Article #1 or  
Article #2 
References for Articles  
Beck depression 
inventory 
Article #1 *Campbell, M. H., Maynard, D., Roberti, J. W., & Emmanuel, 
M. K. (2012). A comparison of the psychometric strengths of 
the public-domain Zung self-rating depression scale with the 
proprietary Beck Depression Inventory-II in Barbados. West 
Indian Medical Journal, 61(5), 483-488. 
Article #2 Jakšić, N., Ivezić, E., Jokić-Begić, N., Surányi, Z., & 
Stojanović-Špehar, S. (2013). Factorial and diagnostic validity 
of the Beck Depression Inventory-II (BDI-II) in Croatian 
primary health care. Journal of clinical psychology in medical 




Article #1 Raimo, S., Trojano, L., Spitaleri, D., Petretta, V., Grossi, D., & 
Santangelo, G. (2015). Psychometric properties of the 
Hamilton Depression Rating Scale in multiple sclerosis. 
Quality of Life Research, 24(8), 1973-1980. 
Article #2 Schneibel, R., Brakemeier, E. L., Wilbertz, G., Dykierek, P., 
Zobel, I., & Schramm, E. (2012). Sensitivity to detect change 
and the correlation of clinical factors with the Hamilton 
Depression Rating Scale and the Beck Depression Inventory in 
depressed inpatients. Psychiatry research, 198(1), 62-67. 
PHQ-9 Article #1 Manea, L., Gilbody, S., & McMillan, D. (2012). Optimal 
cutoff score for diagnosing depression with the Patient Health 
Questionnaire (PHQ-9): a meta-analysis. Canadian Medical 
Association Journal, 184(3), E191-E196. 
PHQ-2 Article #2 Manea, L., Gilbody, S., Hewitt, C., North, A., Plummer, F., 
Richardson, R., & McMillan, D. (2016). Identifying 
depression with the PHQ-2: A diagnostic meta-analysis. 
Journal of affective disorders, 203, 382-395. 
Major depression 
inventory 
Article #1 Bech, P., Timmerby, N., Martiny, K., Lunde, M., & 
Soendergaard, S. (2015). Psychometric evaluation of the 
Major Depression Inventory (MDI) as depression severity 
scale using the LEAD (Longitudinal Expert Assessment of All 
Data) as index of validity. BMC Psychiatry, 15(1), 190. 
Article #2 Fawzi, M. H., Fawzi, M. M., & Abu Hindi, W. (2012). Arabic 
version of the Major Depression Inventory as a diagnostic 
tool: reliability and concurrent and discriminant validity. 
Zung self-rating 
depression scales 
Article #1 *Campbell, M. H., Maynard, D., Roberti, J. W., & Emmanuel, 
M. K. (2012). A comparison of the psychometric strengths of 
the public-domain Zung self-rating depression scale with the 
proprietary Beck depression inventory-II in Barbados. West 
Indian Medical Journal, 61(5), 483-488.  
Article #2 Ruiz-Grosso, P., de Mola, C. L., Vega-Dienstmaier, J. M., 
Arevalo, J. M., Chavez, K., Vilela, A., . . . & Huapaya, J. 
(2012). Validation of the spanish center for epidemiological 
studies depression and Zung self-rating depression scales: a 





Article #1 Levine, S. Z. (2013). Evaluating the seven-item Center for 
Epidemiologic Studies Depression Scale short-form: a 
longitudinal US community study. Social psychiatry and 




Article #2 Chin, W. Y., Choi, E. P., Chan, K. T., & Wong, C. K. (2015). 
The psychometric properties of the Center for Epidemiologic 
Studies Depression Scale in Chinese primary care patients: 
factor structure, construct validity, reliability, sensitivity, and 






Appendix I: Tables 
Table 13 




Reliability of the 
Tools 
Age Groups or 
Demographics for Use 
with the Tool 
Type of Health Care 
Settings 
Advantages of Assessment 
Tools 
Disadvantages of Assessment 
Tools 





First article (by 
Campbell et al., 
2012) 
∝ = 0.88 
 
 
Second article (by 
Jakšić et al., 
2013). At a cutoff 
score of 12 
indicating MDD, 
∝ = 0.89 
Paper version 
appropriate for age 
13 to age 80 
Brevity and 
simplicity of BDI 
makes it a good fit 




-Widely and thoroughly 
researched depression tool 
-Simple to complete, taking 
approximately 5 minutes 
-Available in Spanish 
- Use of cutoff scores to 
designate the level of 
depression 
-BDI more psychometrically 
adequate compared with the 
Zung SDS as seen in 53% of 
respondents completing the 
Zung SDS compared with 81% 
completing the entire 
assessment questions for BDI 
-Wording of Beck’s less 
problematic for patients to 
complete 
-BDI-II was translated into 
many languages 
- Has shown good qualities as 
a tool for screening and 
measuring the severity of 
depression 
-BDI-II has shown strong and 
comparable psychometric 
properties regarding internal 
consistency, factor structure, 
and convergent validity 
-Copyrighted, 
-Costs $ (not in public domain) 
-One BDI item (“loss of 
interest in sex”) has low 
response rate from survey 
participants, which was below 
95% 
-Assessment tool is not free, 
copyrighted and priced per 
assessment 
-Across multiple studies, BDI-
II has inconsistent factor 
structure and is controversial 
-Cutoff scores are not culturally 
independent even though the 
expression of depression may 
differ cross-culturally 
-Optimal cutoff 
for MDD ≥ 12 
-Range of score 































Reliability of the 
Tools 
Age Groups or 
Demographics for Use 
with the Tool 
Type of Health Care 
Settings 
Advantages of Assessment 
Tools 
Disadvantages of Assessment 
Tools 





Article 1 (Raimo, 
Trojano, Spitaleri, 
Petretta, Grossi, & 
Santangelo, 2015) 
∝ = 0.8 
-------------------- 
Article 2 
(Schneibel et al., 
2012) 
(No sensitivity or 
specificity rating 
on the article) 
Observer-rated Hospital setting and 
outpatient 
- Easy to administer and 
acceptable 
-Has fair internal consistency 
with Cronbach’s alpha at 0.8 
Available in multiple 
languages such as French, 
German, Italian, Thai, and 
Turkish. Has interactive voice 
response version (IVR) 
-Available in public domain 
-Assessment based on 
observer-report may be 
susceptible to incorrect 
evaluation based on personal 
traits 
-Assessment procedures can be 
time-consuming 












Article 1 (Manea 
et al., 2012) 
 
-------------------- 
Article 2 (Manea 
et al., 2016) 
PHQ-2: 
PHQ-9 & PHQ-2 are 
self-rating tools 
PHQ-9: Used to 
screen for and 
measure symptoms 
of depression in 









of the first two 
questions of PHQ-9 
(low mood and loss 
of interest/pleasure) 
PHQ-9: Especially designed to 
capture depression diagnosis 
and not for measuring 
depression severity. 
- 
-Free assessment tool 
according to Pfizer Inc, the 
legal copyright holder 
-Takes 5-10 minutes to 
complete the questionnaire and 
1 minute to score 
- Available in multiple 
languages 
Self-rating scale susceptible to 
an erroneous report by patients 
PHQ-9 defined by the DSM-IV 
symptoms of depression, thus, 
not designed for ICD-10 
depression 
-Variation of sensitivity and 
specificity at different cutoff 
points, leading to the 
possibility of false-positive 
results 
For PHQ9: 





1-4: minimal  
5-9: mild  























Reliability of the 
Tools 
Age Groups or 
Demographics for Use 
with the Tool 
Type of Health Care 
Settings 
Advantages of Assessment 
Tools 
Disadvantages of Assessment 
Tools 










Article 2 (Fawzi et 
al., 2012) 
∝ = 0.91 
Self-reporting mood 
questionnaire, usable 
with ICD-10 and 
DSM-V criteria for 




-Developed by World 
Health Organization 
Can be used in any 
health care setting 
-Can be used for depression 
severity measurement from 0 
to 50 scale and also as a 
diagnostic scale. Translated 
into multiple languages. 
Free depression tool 
According to Bech et al. 
(2015), “MDI is superior to the 
Zung SDS and the BDI” 
 
-Available in other languages 
(e.g., German, Turkish, 
Spanish, Danish, French) 
Multiple options for questions 
8 and 10, novice clinician or 
patient can double count 
Cutoff score of  
21 = normal  
21-25 = mild 
26-30= moderate 















(Campbell et al., 
2012) 




Ruiz-Grosso et al. 
(2012) 
For Zung SDS: ∝ = 
0.89 
Adult Can be 
administered in any 
health setting, self-
report tool but 
administered by an 
interview in the 
literature for 
patients with low 
literacy level 
No cost to assessor (available 
in public domain), 
Multiple versions with 
modified recent 
-Short, simple and includes all 
the symptoms of depression 
-Easy to complete in as little as 
5 minutes, scoring instructions 
simple, no training 
requirements 
-Validating instrument for 
depressive in primary care 
setting and diverse patient 
populations 
-Can be used for monitoring 
changes in depression level 
-The response rate to the 20 
Zung SDS was lower than 
95% from one survey 
indicating a problem with 






25-49 = normal 
50-59 = mild  
60-69 = moderate 
> 69 = severe 

















Article 1 (Chin, 













Can be used by 
clinicians for 
diagnosis and to 
manage depression 
over time 




Reliability, sensitivity, and 
responsiveness levels high 
CES-D is a good screening 
tool for depression, monitor 
disease progression and valid 
for use in cross-cultural 
comparative studies. 
-One of the most widely used 
instruments in psychiatric 
epidemiology 
-Free assessment tool 
Self-rating tool- susceptibly 
patient not completing all 
questions on questionnaire 
10% of respondents cease 
halfway on the 20-item CES-
D (Levine, 2013) 
On CES-D: 















While Tables 1, 2 and I3 answered the practice questions, Table I4 is a summary of the articles reviewed for this project. 
The table contains details of the articles, the depression tools evaluated by those articles, the study design, methods of data 





Articles Reviewed for This Project 
Depression 
Inventory Tool 
Article Author, Year Study Design/Methods Level of 
Evidence 




1 Campbell et al. 
(2012) 
-Study compared psychometric properties 
of BDI-II and Zung SDS using 
correlational analyses 
-Missing value analyses and corrected 
item-total correlations were reported as 





N = 415 undergraduate 
students  




marginal superior internal 
consistency, reliability, and 
psychometric properties than 
the Zung SDS 
-Strong correlation between 
BDI-II and Zung’s SDS 
2 Jakšić, Ivezić, 
Jokie-Begic 
Purpose of the study was to examine the 
diagnostic validity of BDI-II 




Croatia N = 314 participants from 
a medical outpatient 
setting 
Ages 25-87 years 
Reliability proved to be high 
using internal consistency 
and Velicer Minimum 




1 Raimo et al. 
(2015) 
-Goal to assess psychometric properties 
of HDRS in screening for depression in 
patients with Multiple sclerosis 
-Internal consistency using Cronbach’s 
alpha with ≥ 70 acceptable 
-Less than 5% missing values or invalid 
items on the HRDS questionnaire 
-Data analysis using SPSS version 20 
-Assessment of construct convergent 
validity, and divergent validity  




Italy 70 selected patients (of 
100 screened) with 
multiple sclerosis in a 
hospital setting from ages 
22-68 with mean age of 
43.3 
11 males  
59 females 
HDRS is an easy tool to 
administer, with a fair 
consistency. 
-Good convergent and 
divergent validity concerning 
Neuropsychiatric inventory 
(NPI) subdomains of 
depression 
2 Schneibel et al. 
(2012) 
Research conducted to determine 
discrepancies and predictive abilities of 
HDRS compared with BDI-II in sensing 
depression severity change 
-Use of analysis of variance 
Peer-
reviewed 
Germany N = 105 hospitalized 
patients with mean age of 
41.6 
HDRS showed a superior 
sensitivity to change 
compared with BDI-II 






Article Author, Year Study Design/Methods Level of 
Evidence 
Setting/ Country Participants Outcome of Study 
PHQ-2/PHQ9 1 Manea et al. 
(2012) 
Goal of project was to summarize 
psychometric properties of PHQ-9 across 
a range of studies 
Random-effects bivariate meta-analysis 
on the optimal cutoff score for diagnosing 







with age range of 24.8 to 
71.4 
The cutoff between 8 and 12 
positively detected depression 
-Recommendation that 
assessment tools should be 
used in conjunction with 
DSM-V or ICD-10 for 
diagnosing depression 
-Same cutoff score not 
recommended for all settings 
2 Manea et al. 
(2016) 
-Research was done to review studies that 
had reviewed psychometric properties of 
PHQ-2 
-Quality assessment was done at study 
level using the revised tool for the quality 
assessment of diagnostic accuracy studies 
(QUADAS-2) 
-Databases searched are MEDLINE, 
PsycINFO, gray literature databases from 
inception to Aug 2014 using search terms 












19 of 21 studies met 
inclusion criteria totaling 
N = 11,175 
What is age of 
participants? 
Data cutoff point of ≥ 3 
indicative of depression while 
the authors recommended 
reading results of the test 
with caution due to high false 
rated. 
Authors believed the 
sensitivity of the PHQ-2 was 
lower than that reported in 
the original validation study, 
hence suggesting lowering 




1 Bech et al., 
(2015) 
-Objective was to evaluate MDI as a 
depression severity scale using 
longitudinal expert assessment of all data 
as an index for validity. 
-The article used data from two 
previously published articles: Study 1 
(Martiny et al., 2005) used a randomized, 
double-blind trial, sample of 102 patients 
Study 2 (Straaso et al., 2014) used a 
randomized, double-blind controlled 
dose-remission-remission study 
The data were analyzed using SAS 
statistical package version 9.0.0 
Peer-
reviewed 
Denmark Study 1: 102 patients 
with mean age of 44.7 
 
Study 2: 65 patients with 
mean age of 48.1 
MDI accepted for measuring 
depression at a cutoff score of 
21, 26, 31 for mild, moderate, 
and severe depression 
respectively 
(table continues) 
2 Fawzi et al. 
(2012) 
Article sought to translate MDI into the 
Arabic language, test its reliability, 
concurrent and discriminant validity of 
Arabic version of MDI 
-Used descriptive statistics, chi-square 
test for categorical and t test 
-Cronbach for internal consistency 
reliability of the MDI-A 
Peer- 
Reviewed 
Egypt N = 100 (50 Egyptian 
outpatients with a 
diagnosis of MDD, and 
50 healthy controls) 
 
The age range of 18-60 
years 
MDI-A (Arabic) has 
excellent reliability, an 
acceptable concurrent and 
discriminant validity 
 
MDI-A has a strong positive 







Article Author, Year Study Design/Methods Level of 
Evidence 
Setting/ Country Participants Outcome of Study 
Zung self-
rating scale 
1 Campbell et al. 
(2012) 
Study compared psychometric properties 
of Zung SDS and BDI-II using 
correlational analyses 
-Missing value analyses and corrected 
item-total correlations were reported as 
well for each assessment tool 





N = 415 undergraduate 




Zung SDS demonstrated 
lower inferior internal 
consistency, reliability, and 
psychometric properties 
compared with BDI-II 
Zung SDS is a valuable tool 
in assessment of adolescents 
and young adults in large 
treatment settings 
2 Ruiz-Grosso et 
al. (2012) 
Study was to validate and compare 
psychometric properties of the Spanish 
version of ZSDS with CES-D 
-Cross-sectional study 
-Cronbach’s Alpha and Hierarchical 
McDonald Omega for polychromic 
variables were used to establish validity 
Peer-
reviewed 
Peru N = 70 patients Zung SDS is a valid 
instrument for detecting 
depression in a clinical 








Chin et al. 
(2015) 
Study was to validate the use of CES-D 
in Chinese primary care patients 
regarding its psychometric properties 
-Assessed convergence validity by 
reviewing correlation between CES-D, 
PHQ-9, and Short Form-12 Health 
Survey (version 2) Mental Component 
Summary, 
Internal consistency assessed with 
McDonald’s Omega hierarchical (wH) 
Peer-
reviewed 
Hong Kong N = 3,686 Chinese adult 
primary care patients in 
Hong Kong 
Age M = 49.4  
58.1% female 
49.9% male 
CES-D has a strong 
correlation with PHQ-9 
Two-week test-retest 
reliability was high 
2 Levine S. 
(2013) 
Study goal was to evaluate potential use 
of the CES-D- SF (with seven items) 
-Reviewed bivariate correlation between 
CES-D and CES-D-SF 
Peer-
reviewed 
U.S.A N = 8500 
 
Ages 28-51 and over 
Compared with CES-D, the 
CES-D-SF also has high 
internal specificity 
 
 
